Dogwood Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-17
-17
-12
EBITDA
-15,728
-3,905
-4,412
-7,572
EBIT
-15,746
-3,923
-4,429
-7,542
Net Income
-15,744
-3,807
-10,924
-7,727
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,272
-4,026
-4,682
-6,131
Cash
10,126
13,402
17,539
14,847
Basic Shares
1,919
1,441
1,441
1,310

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-12
EBITDA
-12,245
-5,446
-12,315
-15,640
EBIT
-12,258
-5,446
-12,315
-15,640
Net Income
-12,349
-5,296
-12,247
-15,960
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,790
-4,870
-11,467
-15,689
Cash
14,847
3,316
7,030
14,008
Basic Shares
1,027
751
442
333

Earnings Calls

QuarterEPS
2025-09-30
-$8.20
2025-06-30
-$1.99
2025-03-31
-$8.45
2024-12-31
-$6.29